Olema Pharmaceuticals announced the appointment of Scott Garland to the company’s Board of Directors. Garland brings more than 30 years of biopharmaceutical industry experience with deep commercial and executive leadership expertise. Garland most recently served as CEO of PACT Pharma, an immuno-oncology company that was focused on developing cell therapies for solid tumors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on OLMA:
- Olema Oncology Appoints Oncology Biotech Executive Scott Garland to Board of Directors
- Olema Oncology Announces Phase 2 Monotherapy Clinical Results to be Presented at the 2023 ESMO Congress
- Olema Oncology KAT6 inhibitor compounds demonstrate anti-tumor activity
- Olema Oncology KAT6 Inhibitor Compounds Demonstrate Potent Anti-Tumor Activity
- Olema Oncology expands collaboration agreement with Novartis
